Correlation Analysis of Anti-SARS-CoV-2 RBD IgG and Neutralizing Antibody against SARS-CoV-2 Omicron Variants after Vaccination

Various vaccines have been developed to control the COVID-19 pandemic, but the available vaccines were developed using ancestral SARS-CoV-2 wild-type (WT) strains. Commercial anti-SARS-CoV-2 receptor binding domain (RBD) antibody assays have been established and employed for validation of vaccine ef...

Descripción completa

Detalles Bibliográficos
Autores principales: Takheaw, Nuchjira, Liwsrisakun, Chalerm, Chaiwong, Warawut, Laopajon, Witida, Pata, Supansa, Inchai, Juthamas, Duangjit, Pilaiporn, Pothirat, Chaicharn, Bumroongkit, Chaiwat, Deesomchok, Athavudh, Theerakittikul, Theerakorn, Limsukon, Atikun, Tajarernmuang, Pattraporn, Niyatiwatchanchai, Nutchanok, Trongtrakul, Konlawij, Kasinrerk, Watchara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9221553/
https://www.ncbi.nlm.nih.gov/pubmed/35741126
http://dx.doi.org/10.3390/diagnostics12061315

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9221553/
https://www.ncbi.nlm.nih.gov/pubmed/35741126
http://dx.doi.org/10.3390/diagnostics12061315

Ejemplares similares